
TY  - JOUR
TI  - INFECTION-RELATED RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_14.x
DO  - doi:10.1111/j.1479-8077.2006.00199_14.x
SP  - A80
EP  - A83
PY  - 2006
ER  - 

TY  - JOUR
TI  - MISCELLANEOUS RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_16.x
DO  - doi:10.1111/j.1479-8077.2006.00199_16.x
SP  - A90
EP  - A99
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 

TY  - JOUR
TI  - ANTI-PHOSPHOLIPID SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_2.x
DO  - doi:10.1111/j.1479-8077.2006.00199_2.x
SP  - A25
EP  - A26
PY  - 2006
ER  - 

TY  - JOUR
TI  - PAEDIATRIC RHEUMATOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_22.x
DO  - doi:10.1111/j.1479-8077.2006.00199_22.x
SP  - A159
EP  - A167
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – TREATMENT
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_24.x
DO  - doi:10.1111/j.1479-8077.2006.00199_24.x
SP  - A188
EP  - A210
PY  - 2006
ER  - 

TY  - JOUR
TI  - SJOGREN'S SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_27.x
DO  - doi:10.1111/j.1479-8077.2006.00199_27.x
SP  - A230
EP  - A234
PY  - 2006
ER  - 

TY  - JOUR
TI  - ALLIED HEALTH PROFESSIONALS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_1.x
DO  - doi:10.1111/j.1479-8077.2006.00199_1.x
SP  - A21
EP  - A25
PY  - 2006
ER  - 

TY  - JOUR
TI  - EPIDEMIOLOGY OF RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_10.x
DO  - doi:10.1111/j.1479-8077.2006.00199_10.x
SP  - A54
EP  - A66
PY  - 2006
ER  - 

TY  - JOUR
TI  - SCLERODERMA AND RELATED SYNDROMES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_26.x
DO  - doi:10.1111/j.1479-8077.2006.00199_26.x
SP  - A225
EP  - A230
PY  - 2006
ER  - 

TY  - JOUR
TI  - DIAGNOSTICS AND IMAGING PROCEDURES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_8.x
DO  - doi:10.1111/j.1479-8077.2006.00199_8.x
SP  - A45
EP  - A51
PY  - 2006
ER  - 

TY  - JOUR
TI  - EDUCATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_9.x
DO  - doi:10.1111/j.1479-8077.2006.00199_9.x
SP  - A52
EP  - A54
PY  - 2006
ER  - 

AU  - Park, Jun S.
AU  - Cho, Ga Y.
AU  - Park, Sung-Il
C7  - pp. 441-462
TI  - Current Research in Korean Herbal Cosmetics
SN  - 9783527340880
UR  - https://doi.org/10.1002/9783527803293.ch25
DO  - doi:10.1002/9783527803293.ch25
SP  - 441-462
KW  - herbal cosmetics
KW  - traditional Korean medicine
KW  - active compounds
KW  - bioprocessing
KW  - skin delivery
PY  - 2006
AB  - Summary Cosmetics based on traditional herbal medicine are formulated not only with herbal extracts but also using advanced bioprocessing and delivery method. This chapter explains the characteristics of Korean herbal cosmetics through examples of concepts, history, and traditions within the Korean traditional medicine industry. With the advancements in biotechnology, studies are now being conducted on the dermatological effects and processing methods of traditional medicinal ingredients, including ginseng. The enzymatic and microbial bioprocessing is used to produce novel natural compounds. Camelliaside A and B and three oxyisoflavones were isolated from the green tea seed and soybean. Using these compounds, a commercially and biologically useful new polyphenol, kaempferol, and 7,3?,4?-trihydroxyisoflavone were produced by enzymatic and microbial bioconversion. Carrier systems, such as liposomes, polymersomes, and solid lipid nanoparticles, are being developed for the stabilization and skin delivery of herbal active compounds.
ER  - 

C7  - pp. 309-329
TI  - Index
SN  - 9780470410110
UR  - https://doi.org/10.1002/9780470891193.index
DO  - doi:10.1002/9780470891193.index
SP  - 309-329
PY  - 2006
ER  - 

TY  - JOUR
AU  - Fernandes, Michelle
AU  - Yang, Xiao
AU  - Li, Jinying Y.
AU  - Cheikh Ismail, Leila
TI  - Smoking during pregnancy and vision difficulties in children: a systematic review
JO  - Acta Ophthalmologica
JA  - Acta Ophthalmol
VL  - 93
IS  - 3
SN  - 9780470410110
UR  - https://doi.org/10.1111/aos.12627
DO  - doi:10.1111/aos.12627
SP  - 213
EP  - 223
KW  - maternal smoking
KW  - pregnancy
KW  - visual impairments
KW  - children
PY  - 2015
AB  - Abstract Cigarette smoking during pregnancy is a major public health concern. Intra-uterine exposure to maternal cigarette smoking is associated with increased risks of growth and neurodevelopmental problems during childhood and later life. Few studies have focussed on visual difficulties in children in the context of maternal smoking during pregnancy. A systematic search of online databases was carried out between February and May 2013 to examine the trend in visual outcomes in children exposed to maternal cigarette smoking during intra-uterine life. Twenty-four non-randomized studies were identified. Each study was rated for quality using the Newcastle-Ottawa Scale. Most studies (n = 18) reported fetal exposure to active or passive maternal cigarette smoking to be associated with an increased risk of adverse visual outcomes in children. In particular, there were higher rates of strabismus, refractive errors and retinopathy among children of women who smoked during pregnancy. These findings suggest that fetal exposure to cigarette smoke is a significant risk factor for visual problems during later life and that certain visual faculties, such as the intraocular muscles and retinal neurons, are more affected than others. The findings provide evidence in support of public health policies aimed at reducing fetal exposure to smoking by advising both women and their partners to quit smoking during pregnancy.
ER  - 
